What are the opening hours?

Monday 9:30am - 5:30pm Tuesday 9:30am - 5:30pm Wednesday 9:30am - 5:30pm Thursday 9:30am - 5:30pm Friday 9:30am - 5:30pm

Cancer Research & Treatment Fund, Inc.

Home
United States
New York, NY
Cancer Research & Treatment Fund, Inc.

The official page of Cancer Research & Treatment Fund. Please follow us to receive our latest news. In 2012, CR&T began funding the Richard T. Silver.

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the establishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornel Medical College. The center was dedicated in a special ceremony on February 18, 2014, and will serve as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Dr. Andrew Schaefer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. For more than three decades, CR&T has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center.

11/26/2025

Stay up-to-date with the most current news and information about CR&T!

Check out our latest news stories, below. https://www.crt.org/latest-news/

11/20/2025

Tonight is the night!

Our annual dinner honors outstanding cancer survivors, medical professionals, and humanitarians for their efforts to raise awareness and accelerate life-saving research. All proceeds benefit CR&T, enabling us to advance treatments and initiate cures for cancer. Meet our honorees!

11/11/2025

🫡 Thank you for your service!

10/28/2025

Living with an can sometimes feel isolating. The CR&T Patient Symposium on MPNs brings patients, caregivers, and specialists together for a day of connection, support, and hope. 💙
Click here to learn more:
https://www.crt.org/patient-symposium-on-mpns/

10/15/2025

FAQs

Polycythemia vera (PV) is a rare blood cancer that causes your body to produce too many red blood cells. This can thicken the blood and increase the risk of clots, stroke, and heart attack.
Many people with PV don’t show symptoms at first — making early detection and awareness critical.

Know the signs. Support the science.

Learn more at crt.org

10/07/2025

CR&T is seeking a dynamic, strategic, and mission-driven leader to join our team as Vice President of Development and Administration.

In this executive role, you'll drive our fundraising strategy, oversee organizational operations, and help shape the future of CR&T.

📌 Details & How to Apply: https://www.indeed.com/viewjob?jk=2186158b9445b501

Help us spread the word or apply today to be part of something meaningful.

09/29/2025

Fatigue is common in patients with myeloproliferative neoplasms and can be due to a number of reasons. The excessive production of blood cells and inflammato...

09/26/2025

We are pleased to announce that Dr. Ghaith Abu-Zeinah, Assistant Professor at Weill Cornell Medicine, CR&T Medical Advisory Board Member, and CR&T International MPN Patient Symposium Chair, will serve as Cancer Research and Treatment Fund’s new Vice President and Chief Medical Officer. 👏👏👏👏

09/25/2025

🫀 Did you know that (PV) and (ET) can put extra strain on the heart?

At the CR&T Patient Symposium on , hear from a leading cardiologist who will explain how MPNs affect the cardiovascular system — and what patients and caregivers can do to better protect heart health.

📅 Don’t miss this important session designed to give you practical knowledge that goes beyond blood counts.

https://www.crt.org/patient-symposium-on-mpns/

09/24/2025

FAQs ⁉
What is interferon and how is it used for MPNs?

Interferon is a group of natural products the body makes in response to viral infections in an effort to attack the virus. Several interferon types have been...

09/22/2025

Special bonus: Patients who register for the CR&T Patient Symposium on MPNs will receive an exclusive discount (upon request) to attend the MPN International Congress the following day — a unique chance to hear the latest scientific updates usually shared only among physicians.

Register today! 👉👉 https://www.crt.org/patient-symposium-on-mpns/

09/18/2025

Every individual diagnosed with a myeloproliferative neoplasm may experience different side effects. Side effects can range from more serious, such as fever,...

Address

500 E 77th Street, Ste 1001
New York, NY
10162

Opening Hours

Monday	9:30am - 5:30pm
Tuesday	9:30am - 5:30pm
Wednesday	9:30am - 5:30pm
Thursday	9:30am - 5:30pm
Friday	9:30am - 5:30pm

Website

http://www.crt.org/

Alerts

Be the first to know and let us send you an email when Cancer Research & Treatment Fund, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cancer Research & Treatment Fund, Inc.:

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?

Our Story

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the establishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . In 2012, CR&T began funding the Richard T. Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornell Medical College. The center was dedicated in a special ceremony on February 18, 2014, and serves as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Silver. Dr. Andrew Schafer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. CR&T will mark its 50th Anniversary in 2018. For nearly 50 years, the organization has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center, and Memorial Sloan-Kettering Cancer Center.